News of Note—Cancer diagnostics startup Celcuity files for $15M IPO

News of note

> Cancer diagnostics startup Celcuity filed to raise up to $15 million in an IPO. The Minneapolis-based company is working on its CELx platform, which analyzes live tissue to pinpoint the specific abnormal activity that drives a patient’s cancer. Release

> The FDA cleared Titan Pharmaceuticals’ phase 1/2 clinical study of its ropinirole-delivering implant for the treatment of Parkinson’s disease. Release

Suggested Articles

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.

Precision oncology firm Notable Labs is launching its first self-sponsored clinical trial, designed from the ground up to help validate its platform.